摘要
目的了解新冠疫情发生后湖南省居民用药知识-态度-行为(KAP)状态和影响因素,为后疫情时代进行更有效的合理用药科普宣教提供参考。方法于2020年5月-7月对湖南省不同地区居民开展用药KAP线上问卷调查,分析居民用药知识、态度和行为的情况及影响因素。结果共收到有效问卷1512份。居民用药知识、态度和行为平均得分分别为(59.32±20.22)、(33.09±8.80)和(56.95±10.52)分,均达到评价标准中的"良好",但行为得分较2018年在湖南省进行的KAP调查增加。多元线性回归分析表明,新冠疫情后显著影响居民用药KAP的因素包括年龄、居住地、医疗保障状况、受教育程度和工作状况。结论疫情发生后湖南省居民用药KAP情况整体良好,但不安全用药行为风险较疫情前有所增加。后疫情时代应根据防疫要求和时代特点,利用多种平台与手段进行用药宣教,尤其应加强对老年人、居住在农村、低教育水平和无业人群的用药教育。
Objective To investigate the status and influencing factors of KAP (knowledge-attitude-practice,KAP) among residents in Hunan province during the COVID-19 epidemic to provide reference for more effective education of rational drug usage in the near future.Methods The online KAP questionnaire survey on medication safety was conducted among residents in different areas of Hunan province from May to July,2020,and the status and influencing factors of knowledge,attitude and practice of medication usage were analyzed.Results Totally of 1512 valid questionnaires were received.The average scores of medication knowledge,attitude and practice of residents were (59.32±20.22),(33.09±8.80) and (56.95±10.52),respectively,all meeting the “good” grade in the evaluation criteria.However,the average practice score was higher than the one conducted in 2018 in Hunan province.Multiple linear regression analysis showed that the factors significantly affecting residents’ knowledge,attitude and practice of medication usage included age,place of living,medical insurance status,education background and working status.Conclusion After the outbreak of the COVID-19,the knowledge,attitude and practice of medication usage of residents in Hunan province are generally good.However,the risk of unsafe medicine usage behavior has increased after the epidemic.In the post-epidemic era,we should use a variety of platforms and means to carry out medication safety education,especially focusing on the elderly,people living in rural areas,residence with low educational level and the unemployed.
作者
何丹
梁群
张超
陈婷
刘欣
钟佳
邓婷
谭胜蓝
HE Dan;LIANG Qun;ZHANG Chao;CHEN Ting;LIU Xin;ZHONG Jia;DENG Ting;TAN Sheng-lan(Department of Pharmacy,Institute of Clinical Pharmacy,Second Xiangya Hospital,Central South University,Changsha 410011;Department of Pharmacy,921 Hospital of Chinese People’s Liberation Army Joint Logistics Support Force,Changsha 410003;Department of Pharmacy,Jiangxi Provincial Cancer Hospital,Nanchang 330029;Hunan Pharmaceutical Association,Changsha 410011;Nanxian People’s Hospital,Yiyang Hunan 413299;People’s Hospital of Wangcheng District,Changsha 410200)
出处
《中南药学》
CAS
2021年第12期2675-2679,共5页
Central South Pharmacy
基金
湖南省科学技术厅惠普性政策与创新环境建设计划(No.2020ZK4080)
湖南省居民用药安全行为风险KAP调查研究(No.CMEI2020KPYJ0015)
吴阶平医学基金会(No.320.6750.2020-04-36)。